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It is Time to Give Social Research a Voice to Tackle AMR 18 
Sir, 19 
We have noted the recent review by Zellweger et al. with great interest.1 The authors highlight trends 20 
and challenges in antimicrobial resistance (AMR) in Southeast Asia and – encouragingly for us as 21 
social researchers – point out the need for social science research in a field that is dominated by the 22 
medical and biological sciences. We, too, call for more social research to understand and address 23 
antimicrobial use and resistance, but this will require a stronger voice for social scientists. 24 
Considering that antimicrobial use and resistance “have a large behavioural component,”1 the near-25 
absence of social sciences research in AMR prevents comprehensive understanding and effective 26 
policy responses. Take for instance something as seemingly simple as the language to communicate 27 
the problem of antimicrobial resistance to the general population. Mendelson et al. alluded in a recent 28 
comment to the lacking popular awareness of “antimicrobial resistance” and the problematic 29 
translation of the term into other languages.2 In our own social research in rural northern Thailand 30 
(Chiang Rai; a mostly rural district with 1.3 million inhabitants),3 we have also come across varied 31 
expressions of “antibiotics.” For example, rather than “wonder drugs,” antibiotics are often referred to 32 
as “anti-inflammatory medicine” (“ยาแก้อกัเสบ” or “yah kae ak seb”), which links to local descriptions of 33 
illnesses as being caused by “inflammations” of the body (e.g. in the case of a sore throat). Moreover, 34 
some local ethnic groups in Chiang Rai (e.g. Akha) may not have an equivalent of the Thai term in 35 
their mother tongue and rather refer to antibiotics as the “medicine that relieves the pain,” and yet other 36 
people would not actively distinguish between antibiotics and other kinds of medicine.i The literal 37 
                                                 
i These are not the only examples, and our informants also had a wide range of notions and descriptions for other medicines 
ranging from brand names (e.g. Tiffy) via generic descriptions (fever reliever) to descriptions of appearance (“the white 
pill”). 
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translation of “antibiotic” (“ยาปฏิชีวนะ” or “yah pa ti chee wa na”) is a technical term with Pali roots (akin 38 
to Latin) that is hardly used or understood in rural Chiang Rai. Even seemingly unambiguous 39 
expressions like “drug resistance” (“ดือ้ยา” or “due yah”)—literally translated into being “stubborn to 40 
[the effects of] medicine”—are being interpreted by non-native speakers or people without active 41 
conceptions of antibiotic resistance as meaning “stubborn to take medicine.” Language is therefore not 42 
merely a means to overcome “irrational behaviour” but it also reflects more fundamentally how people 43 
think about medicine and illness. We first need to understand and address such deeper-rooted local 44 
conceptions and behaviours involving antimicrobial use. AMR information campaigns referring for 45 
example to “antibiotics,” “bacteria,” or “viruses” could otherwise be fruitless or have unforeseen 46 
behavioural repercussions.4 47 
In addition, the common policy emphasis on education and “awareness raising” to address behavioural 48 
aspects of AMR5-8 assumes that “irrational” choices are the main driver behind problematic 49 
antimicrobial-related behaviour (e.g. over- or under-use of antibiotics), but not all medicine 50 
consumption is the result of active choice. Social, economic, and health system constraints may drive 51 
people into behaviours where they may be more likely to access antimicrobials—knowingly or 52 
unknowingly. Not only do we need qualitative as well as quantitative social research to understand the 53 
nature and extent of such structural constraints of antimicrobial use (note that the social sciences are 54 
neither a homogeneous field nor synonymous to qualitative research).ii In terms of AMR policy, these 55 
broader determinants of behaviour also require us to think beyond medical and health policy solutions. 56 
                                                 
ii The various social science disciplines could make different contributions to the field of AMR. For example, social 
anthropologists and historians might situate current antibiotic usage patterns in a broader social and historical context in 
order to understand their meaning and origin, microeconomists might consider the role of individual incentives in 
healthcare choices, or development studies researchers might examine the distribution of power from the micro to the 
macro level to understand pitfalls, failures, and inequities associated with AMR-related interventions. 
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Might for instance sick leave, social protection policies, access to financial services like loans and 57 
savings accounts, or more efficient public transport alleviate some of the constraints that shape the 58 
antimicrobial use among groups who lack access to medical supervision? 59 
Social scientists do not hold a monopoly on social research questions, and the appreciation of social 60 
phenomena by medical AMR researchers is laudable indeed. Yet, the continuing absence of social 61 
research is a threat to understanding and addressing the social dimensions of AMR more 62 
comprehensively and effectively. 63 
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